Sildenafil citrate
- Level
- Commodity
- Parent
- 51413200
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51413207This classification denotes a cgmp phosphodiesterase inhibitor with the molecular formula C22H30N6O4S.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BW9B0ZE037, chemically known as 1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate (1:1) but more generally known as sildenafil citrate, which bears US NIH Compound Identifier 62853. European Medicines Agency schedules Sildenafil citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04386MIG. Most nations, for tariff and trade purposes, schedule sildenafil citrate under HS 29350090 and SITC 51580. As of Q4 2014, SILDENAFIL CITRATE remains US FDA's Preferred Term for this commodity. Sildenafil citrate bears US NLM identifiers UMLS ID C0724693 and NCI Concept Code C26670. SMILES: CCCC1C2C(C(=O)[NH]C(N2)C3CC(CCC3OCC)S(=O)(=O)N4CCN(CC4)C)N(N1)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.
Same parent
Under 51413200 · 13Activities that produce or sell this
KBLI · 8Inherited from family 51410000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.